TerminatedEUCTR 2008-003421-17
Efficacy and safety of agomelatine (25 mg/day with potential blinded adjustment at 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomised, dou...
This historical record does not confirm current site availability.
Historical research recordCzechia + Slovakia
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who could participate?
This study is for people with anxiety. Other eligibility criteria apply.
- Listed locations
- Czechia · Slovakia
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 390
- Sponsor
- Institut de Recherches Internationales Servier
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Czechia, Slovakia
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2008-003421-17
- Official title
Show the full official title
Efficacy and safety of agomelatine (25 mg/day with potential blinded adjustment at 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomised, dou...
Recruitment & locations
TerminatedCzechia · Slovakia
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Institut de Recherches Internationales Servier, a research institute.
Who can participate?
This study is for people with anxiety. Other eligibility criteria apply.
Is this study still recruiting?
The historical registry lists this study as terminated.
